| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 18,272 | 19,170 | 14,991 | 16,686 | | Cost of Revenue | 2,690 | 4,565 | 2,918 | 2,813 | | | Gross Profit | 15,582 | 14,605 | 12,073 | 13,873 | | | Operating Expenses | | Research Development | 2,853 | 2,150 | 2,168 | 2,871 | | Selling General and Administrative | 13,137 | 14,335 | 13,351 | 18,823 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (408) | (1,880) | (3,446) | (7,821) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (123) | 38 | (58) | (3) | | Earnings Before Interest And Taxes | (510) | (1,842) | (3,504) | (7,824) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (510) | (1,842) | (3,504) | (7,824) | | Income Tax Expense | 49 | 35 | 61 | 59 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (559) | (1,877) | (3,565) | (7,883) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (559) | (1,877) | (3,565) | (7,883) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($559) | ($1,877) | ($3,565) | ($7,883) |
|
0.40% Nasdaq 
Income Statement
